INVO Bioscience Announces Appointment of Barbara Ryan and Matthew Szot to the Board of Directors

Sep 16, 2020 | Press Releases

INVO’s Board strengthened with independent directors as we enter a new growth trajectory for the CompanySARASOTA, Fla., Sept. 16, 2020 — INVO Bioscience, Inc. (OTCQB: INVO), a medical device company focused on creating alternative treatments for patients...

INVO Bioscience Reports Second Quarter 2020 Financial Results

Aug 13, 2020 | Press Releases

Company to Provide Investor Update During Virtual Investor Conference on August 19 at 2:00pm ET (Details Below); Management Available for Virtual 1×1 MeetingsSARASOTA, Fla., Aug. 13, 2020 – INVO Bioscience, Inc. (OTCQB: INVO), a medical device company...

INVO Bioscience to Present at the August 2020 Lytham Partners Virtual Investor Growth Conference

Aug 6, 2020 | Press Releases

SARASOTA, Fla., Aug. 6, 2020 – INVO Bioscience, Inc. (OTCQB: INVO), (“the Company”, “INVO”) a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of...

INVO Bioscience Receives Registration Approval for INVOcell in Turkey

Jul 16, 2020 | Press Releases

– An estimated 15% to 20% of the Turkish population suffers from the difficulty of conceiving- “As the world’s only Intravaginal Culture System, INVOcell, a streamlined treatment solution, is uniquely positioned to address the challenges within the...

America Institute for Reproductive Medicine of Birmingham Alabama (“AIRM”) Spotlights its Success in the Use of INVOcell

Jul 2, 2020 | Press Releases

– According to AIRM, “IVF with INVOcell is a simple, cost-effective, and highly rewarding methodology to increase access to care for assisted reproduction”- Industry forecasts suggest that only 1% to 2% of the estimated 150 million infertile couples...